Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels (Q74615754)
Jump to navigation
Jump to search
scientific article published on 01 August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels |
scientific article published on 01 August 2002 |
Statements
Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels (English)
G Batist
F Patenaude
P Champagne
D Croteau
C Levinton
C Hariton
B Escudier